LATEST TRIALS

  • Melanoma
    A Phase Ib/II Randomised Open Label Study of BGB324 in Combination With Pembrolizumab or Dabrafenib Compared to Pembrolizumab or Dabrafenib Monotherapy, in Patients With Advanced Non-resectable (Stage IIIc) or Metastatic (Stage IV) Melanoma
  • Solide Tumores
    Safety and pharmacokinetics of ODM-207 in patienst with selected advanced tumors; an open-label, non-randomosed, uncontrolled, multicentre, first-in-human study with cohort expansion
  • Sarcoma
    A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Trial of Crenolanib in Subjects with Advanced or Metastatic Gastrointestinal Stromal Tumors with a D842V Mutation in the PDGFRA Gene

NORDIC COOPERATION

Norway Norway Sweden Finland Aarhus Herlev Copenhagen